Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 49-55

  Moalem, Gila ^a   Leibowitz Amit, Raya ^a   Yoles, Eti ^a   Mor, Felix ^a   Cohen, Irun R ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; FEMALE; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNITY; AXOTOMY; CENTRAL NERVOUS SYSTEM; FEMALE; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; NERVE DEGENERATION; NEURONS; OPTIC NERVE; OPTIC NERVE INJURIES; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 0033049143     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4734     Document Type: Article

References (15)

1. Streilein, J.W. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5, 428-432 (1993).
2. Streilein, J.W. Unraveling immune privilege. Science 270, 1158-1159 (1995).
3. Lazarov Spiegier, O. et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10, 1296-1302 (1996).
4. Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med. 4, 814-821 (1998).
5. Hickey, W.F., Hsu, B.L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991).
6. Ben Nun, A., Wekerle, H. & Cohen, I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199 (1981).
7. Ota, K. et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183-187 (1990).
8. Martin, R. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies. J. Neural Transm. Suppl. 49, 53-67 (1997).
9. Burns, J., Rosenzweig, A., Zweiman, B. & Lisak, R.P. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell. Immunol. 81, 435-440 (1983).
10. Pette, M et al. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87, 7968-7972 (1990).
11. Martin, R. et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540-548 (1990).
12. Schluesener, H.J. & Wekerle, H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135, 3128-3133 (1985).
13. Hirschberg, D.L. et al. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J. Neuroimmunol. 89, 88-96 (1998).
14. Faden, A.I. & Salzman, S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29-35 (1992).
15. Faden, A.I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7, 175-186 (1993).